Citadel Advisors LLC acquired a new position in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,172 shares of the company’s stock, valued at approximately $341,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of TRHC. UBS Asset Management Americas Inc. acquired a new stake in shares of Tabula Rasa HealthCare during the fourth quarter worth $9,559,000. Peregrine Capital Management LLC acquired a new stake in shares of Tabula Rasa HealthCare during the fourth quarter worth $9,122,000. Pier Capital LLC acquired a new stake in shares of Tabula Rasa HealthCare during the third quarter worth $4,151,000. Wasatch Advisors Inc. acquired a new stake in shares of Tabula Rasa HealthCare during the third quarter worth $4,047,000. Finally, EAM Investors LLC acquired a new stake in shares of Tabula Rasa HealthCare during the third quarter worth $3,931,000. Institutional investors own 53.03% of the company’s stock.
Several research firms have recently weighed in on TRHC. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. BidaskClub cut shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Citigroup began coverage on shares of Tabula Rasa HealthCare in a research report on Thursday, January 4th. They set a “buy” rating for the company. Oppenheimer began coverage on shares of Tabula Rasa HealthCare in a research report on Monday, December 18th. They set an “outperform” rating and a $35.00 price objective for the company. Finally, William Blair began coverage on shares of Tabula Rasa HealthCare in a research report on Monday, December 11th. They set an “outperform” rating for the company. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Tabula Rasa HealthCare presently has an average rating of “Buy” and a consensus price target of $29.78.
Shares of Tabula Rasa HealthCare Inc (NASDAQ TRHC) opened at $37.80 on Tuesday. The company has a quick ratio of 0.66, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. The company has a market cap of $725.08 and a price-to-earnings ratio of -222.35. Tabula Rasa HealthCare Inc has a twelve month low of $11.59 and a twelve month high of $39.81.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings results on Monday, March 12th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.02). The company had revenue of $43.93 million during the quarter, compared to analyst estimates of $38.91 million. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The company’s revenue for the quarter was up 60.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.10 earnings per share. equities analysts predict that Tabula Rasa HealthCare Inc will post 0.03 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Citadel Advisors LLC Takes Position in Tabula Rasa HealthCare Inc (TRHC)” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://sportsperspectives.com/2018/03/13/citadel-advisors-llc-takes-position-in-tabula-rasa-healthcare-inc-trhc.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.